Could high calcium indicate hyperparathyroidism or cancer?

High calcium levels can indicate hyperparathyroidism in 80-90% of cases, while cancer accounts for about 10% of hypercalcemia cases. Both conditions require medical evaluation, but hyperparathyroidism is far more common and often treatable with surgery.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Finding out you have high calcium levels in your blood can be concerning, especially when you start researching potential causes. While elevated calcium (hypercalcemia) can indeed signal serious conditions like hyperparathyroidism or cancer, it's important to understand that hyperparathyroidism is by far the most common cause, accounting for about 80-90% of cases in outpatient settings. Cancer-related hypercalcemia, while serious, represents only about 10% of cases and typically occurs in people with advanced, already-diagnosed cancers.

Understanding what your calcium levels mean, recognizing symptoms, and knowing when to seek medical attention can help you navigate this health concern with clarity. This article explores the relationship between high calcium, hyperparathyroidism, and cancer, along with practical steps you can take to monitor and manage your health.

Understanding Normal vs. High Calcium Levels

Calcium is essential for bone health, muscle function, nerve signaling, and blood clotting. Your body tightly regulates calcium levels through a complex system involving your parathyroid glands, kidneys, bones, and intestines. Normal blood calcium levels typically range from 8.5 to 10.2 mg/dL, though this can vary slightly between laboratories.

Calcium Level Categories and Clinical Significance

Calcium levels should be interpreted with albumin levels and clinical context. Corrected calcium = total calcium + 0.8 × (4.0 - albumin level).
Calcium Level (mg/dL)CategoryClinical SignificanceCommon Symptoms
8.5-10.28.5-10.2NormalHealthy rangeNone
10.3-11.510.3-11.5Mild hypercalcemiaOften asymptomatic, may indicate early diseaseFatigue, mild cognitive changes
11.6-13.011.6-13.0Moderate hypercalcemiaUsually symptomatic, requires evaluationNausea, confusion, polyuria, constipation
>13.0>13.0Severe hypercalcemiaMedical emergencySevere confusion, cardiac arrhythmias, coma

Calcium levels should be interpreted with albumin levels and clinical context. Corrected calcium = total calcium + 0.8 × (4.0 - albumin level).

Hypercalcemia is diagnosed when calcium levels exceed 10.2-10.5 mg/dL. However, it's crucial to consider albumin levels when interpreting results, as calcium binds to this protein in your blood. Your doctor may calculate a "corrected calcium" level or order an ionized calcium test for more accurate assessment. Understanding your calcium levels through comprehensive testing can provide valuable insights into your overall health status.

Factors That Can Affect Calcium Readings

  • Dehydration can falsely elevate calcium levels
  • Low albumin levels can make total calcium appear lower than it actually is
  • Certain medications like thiazide diuretics can increase calcium
  • Time of day and posture during blood draw can influence results
  • Laboratory variations in measurement techniques

Hyperparathyroidism: The Most Common Culprit

Primary hyperparathyroidism occurs when one or more of your four parathyroid glands (tiny glands behind your thyroid) produce too much parathyroid hormone (PTH). This excess PTH causes your body to release calcium from bones and absorb more calcium from food, leading to elevated blood calcium levels.

Types and Causes of Hyperparathyroidism

Primary hyperparathyroidism typically results from a benign tumor (adenoma) on one parathyroid gland in about 85% of cases. Multiple gland involvement occurs in 15% of cases, while parathyroid cancer is extremely rare, accounting for less than 1% of cases. The condition affects approximately 1 in 1,000 people, with women being three times more likely to develop it than men, especially after menopause.

Secondary hyperparathyroidism develops when another condition, such as chronic kidney disease or severe vitamin D deficiency, causes low calcium levels. The parathyroid glands respond by producing more PTH to compensate. Tertiary hyperparathyroidism can occur in long-standing secondary cases when the glands become autonomous.

Symptoms of Hyperparathyroidism

Many people with mild hyperparathyroidism have no symptoms, which is why the condition is often discovered incidentally during routine blood work. When symptoms do occur, they can be remembered by the phrase "stones, bones, groans, and psychiatric overtones":

  • Kidney stones (stones)
  • Bone pain, osteoporosis, or fractures (bones)
  • Abdominal pain, nausea, or constipation (groans)
  • Depression, anxiety, memory problems, or fatigue (psychiatric overtones)
  • Excessive thirst and frequent urination
  • Muscle weakness
  • High blood pressure

Cancer-Related Hypercalcemia

While less common than hyperparathyroidism, cancer can cause high calcium levels through two main mechanisms. Understanding these mechanisms helps explain why cancer-related hypercalcemia typically occurs in people with advanced, already-diagnosed cancers rather than being the first sign of malignancy.

How Cancer Causes High Calcium

Humoral hypercalcemia of malignancy (HHM) accounts for about 80% of cancer-related cases. In HHM, cancer cells produce a protein called PTH-related peptide (PTHrP) that mimics parathyroid hormone, causing increased calcium release from bones and decreased calcium excretion by kidneys. This is most common in squamous cell cancers of the lung, head and neck, as well as breast, kidney, and bladder cancers.

Local osteolytic hypercalcemia occurs when cancer spreads to bones, causing direct bone destruction and calcium release. This mechanism is common in multiple myeloma, breast cancer, and lung cancer with bone metastases. The combination of tumor cells and activated immune cells creates an environment that accelerates bone breakdown.

Key Differences from Hyperparathyroidism

Cancer-related hypercalcemia typically presents differently from hyperparathyroidism. Calcium levels tend to be higher (often above 14 mg/dL) and rise more rapidly. Patients usually have known cancer or obvious symptoms like unexplained weight loss, night sweats, or palpable masses. PTH levels are suppressed or normal, unlike in hyperparathyroidism where they're elevated. The prognosis is generally poor, with median survival of 30-60 days without treatment.

Other Causes of High Calcium

While hyperparathyroidism and cancer are the most concerning causes, several other conditions can elevate calcium levels:

  • Vitamin D intoxication from excessive supplementation
  • Granulomatous diseases like sarcoidosis or tuberculosis
  • Hyperthyroidism (overactive thyroid)
  • Adrenal insufficiency
  • Prolonged immobilization leading to bone breakdown
  • Certain medications including lithium, thiazide diuretics, and calcium supplements
  • Milk-alkali syndrome from excessive calcium carbonate intake
  • Familial hypocalciuric hypercalcemia (FHH), a benign genetic condition

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Testing and Evaluation

If you have high calcium levels, your doctor will order additional tests to determine the cause. The diagnostic workup typically follows a systematic approach to distinguish between different causes of hypercalcemia.

Essential Laboratory Tests

The most important initial test is measuring PTH levels alongside calcium. In primary hyperparathyroidism, PTH is inappropriately elevated or high-normal despite high calcium. In cancer and most other causes, PTH is suppressed. Additional tests may include ionized calcium, 24-hour urine calcium, vitamin D levels, and kidney function tests. If you're interested in monitoring your calcium levels and overall metabolic health, comprehensive at-home testing can provide convenient access to these important biomarkers.

If PTH is suppressed, your doctor may order PTHrP levels to check for humoral hypercalcemia of malignancy, along with a comprehensive metabolic panel, complete blood count, and specific cancer markers based on your symptoms and risk factors.

Imaging Studies

For suspected hyperparathyroidism, imaging helps locate abnormal parathyroid glands before surgery. Common studies include neck ultrasound, sestamibi scan (a nuclear medicine test), or 4D-CT scan. These tests have varying sensitivities and are often used in combination.

If cancer is suspected, imaging focuses on finding the primary tumor and assessing for metastases. This might include chest X-ray or CT, mammography, colonoscopy, or PET scan, depending on clinical suspicion.

Treatment Approaches

Treatment depends entirely on the underlying cause and severity of hypercalcemia. Mild, asymptomatic cases may only require monitoring, while severe hypercalcemia is a medical emergency requiring immediate intervention.

Managing Hyperparathyroidism

Surgery (parathyroidectomy) is the only cure for primary hyperparathyroidism and is recommended for symptomatic patients or those meeting specific criteria including calcium levels above 11.5 mg/dL, osteoporosis, kidney stones, or age under 50. Success rates exceed 95% when performed by experienced surgeons.

For patients who aren't surgical candidates or have mild disease, medical management includes adequate hydration, moderate calcium intake (not restriction), regular weight-bearing exercise, and medications like cinacalcet to lower calcium levels or bisphosphonates to protect bones.

Acute management involves aggressive IV hydration to promote calcium excretion, followed by bisphosphonates like zoledronic acid or pamidronate to inhibit bone breakdown. Calcitonin provides rapid but temporary calcium reduction. Denosumab, a monoclonal antibody, is effective for bisphosphonate-resistant cases.

Long-term management focuses on treating the underlying cancer with chemotherapy, radiation, or targeted therapy. Unfortunately, hypercalcemia often indicates advanced disease with limited treatment options.

When to Seek Medical Attention

Certain symptoms warrant immediate medical evaluation as they may indicate severe hypercalcemia or underlying serious conditions:

  • Confusion, difficulty thinking clearly, or altered mental status
  • Severe nausea and vomiting leading to dehydration
  • Extreme fatigue or muscle weakness
  • Irregular heartbeat or palpitations
  • Severe constipation or abdominal pain
  • Excessive thirst and urination despite adequate fluid intake
  • New or worsening bone pain

Even without severe symptoms, any persistently elevated calcium level deserves evaluation. Early detection of hyperparathyroidism allows for timely treatment before complications develop, while ruling out cancer provides peace of mind.

Living with High Calcium: Practical Tips

While awaiting diagnosis or managing mild hypercalcemia, certain lifestyle modifications can help minimize symptoms and prevent complications:

  • Stay well-hydrated with 8-10 glasses of water daily to help kidneys excrete calcium
  • Remain physically active to maintain bone health and prevent calcium loss from bones
  • Avoid calcium supplements unless specifically prescribed by your doctor
  • Limit vitamin D supplements without medical supervision
  • Monitor sodium intake as high salt consumption increases calcium excretion
  • Keep a symptom diary to track patterns and triggers
  • Attend all follow-up appointments for calcium monitoring

Regular monitoring through blood tests helps track calcium trends and treatment effectiveness. For those managing hyperparathyroidism or at risk for metabolic complications, comprehensive biomarker testing can provide insights into bone health, kidney function, and overall metabolic status.

The Bottom Line: Knowledge Reduces Anxiety

While discovering high calcium levels can trigger worry about serious conditions like cancer, remember that hyperparathyroidism is far more likely and highly treatable. Cancer-related hypercalcemia rarely presents as an isolated finding in otherwise healthy individuals. Most people with cancer-related high calcium already know they have cancer.

The key is proper evaluation to determine the cause. With appropriate testing including PTH levels, imaging when indicated, and systematic workup, doctors can usually identify the underlying condition quickly. Whether dealing with hyperparathyroidism, cancer, or another cause, effective treatments exist to manage hypercalcemia and address its root cause.

If you've been diagnosed with high calcium, work closely with your healthcare team to determine the cause and develop an appropriate treatment plan. Early intervention often leads to better outcomes, and many people with treated hyperparathyroidism go on to live completely normal lives with regular monitoring.

References

  1. Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018;14(2):115-125.[PubMed][DOI]
  2. Mirrakhimov AE. Hypercalcemia of Malignancy: An Update on Pathogenesis and Management. N Am J Med Sci. 2015;7(11):483-493.[PubMed][DOI]
  3. Bilezikian JP, et al. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561-3569.[PubMed][DOI]
  4. Zagzag J, et al. Hypercalcemia and cancer: Differential diagnosis and treatment. CA Cancer J Clin. 2018;68(5):377-386.[PubMed][DOI]
  5. Minisola S, et al. The diagnosis and management of hypercalcaemia. BMJ. 2015;350:h2723.[PubMed][DOI]
  6. Shane E. Clinical review 122: Parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86(2):485-493.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my calcium levels at home?

You can test your calcium at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive metabolic testing. While the base program doesn't include calcium, you can monitor related metabolic markers that help assess your overall health status.

What is the normal range for blood calcium?

Normal blood calcium levels typically range from 8.5 to 10.2 mg/dL, though this can vary slightly between laboratories. Levels above 10.5 mg/dL are generally considered elevated and warrant further investigation.

How quickly do calcium levels rise with cancer vs hyperparathyroidism?

Cancer-related hypercalcemia typically causes rapid rises in calcium, often reaching levels above 14 mg/dL within weeks. Hyperparathyroidism usually causes a gradual increase over months to years, with levels rarely exceeding 12 mg/dL.

Can high calcium levels be temporary?

Yes, calcium levels can be temporarily elevated due to dehydration, certain medications, or excessive vitamin D supplementation. However, persistently high levels require medical evaluation to rule out underlying conditions.

What's the difference between total and ionized calcium?

Total calcium measures all calcium in your blood, including calcium bound to proteins. Ionized calcium measures only the free, active calcium. Ionized calcium is more accurate but requires special handling, so total calcium with albumin correction is commonly used.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details